Literature DB >> 7647978

Drug-induced defaecation in rats: role of central 5-HT1A receptors.

T Croci1, M Landi, A Bianchetti, L Manara.   

Abstract

1. We investigated the acute effects of 5-hydroxytryptamine (5-HT), and of the 5-HT1A receptor agonists, 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), buspirone and SR 57746A, on rat faecal pellet output and water content. 2. 5-HT, 8-OH-DPAT, buspirone and SR 57746A, a new selective 5-HT1A receptor agonist, displaced [3H]-8-OH-DPAT from specific binding sites in rat hippocampus membranes (Ki, nM; 1.8, 1.2, 15, 3.1 respectively) and stimulated rat defaecation dose-dependently. SR 57746A and buspirone induced 1 g dry weight of faeces at 1.3 and 6.1 mg kg-1, p.o. (AD1) respectively. 8-OH-DPAT and 5-HT stimulated defaecation after s.c. injection (AD1, 0.07 and 7.5 mg kg-1, respectively). All these agents increased faecal water content. 3. The putative 5-HT1A receptor antagonist, pindolol, injected s.c. or i.c.v., significantly reduced the defaecation induced by systemically administered 8-OH-DPAT, buspirone or SR 57746A, but not 5-HT. 4. Pretreatment with p-chlorophenylalanine (i.p.) or 5,7-dihydroxytryptamine (i.c.v.), according to protocols designed to cause either generalized or CNS-limited 5-HT depletion respectively, also reduced the defaecation induced by buspirone or SR 57746A. 5. No specific 5-HT1A binding sites could be labelled by incubating rat colon membranes with [3H]-8-OH-DPAT, and in vitro preparations of rat colon segments showed no response to 8-OH-DPAT or SR 57746A up to 5 microM. 6. After eight days' repeated daily treatment, complete tolerance developed to the stimulant effects of SR 57746A and buspirone on faecal water content, but not on faecal pellet output. This suggests that faecal mass excretion and water exchange through the gut wall are affected by independent mechanisms.7. The present findings support the involvement of central 5-HTIA receptors in intestinal propulsion and regulation of luminal fluid content, presumably accounting for the drug-induced defaecation in rats.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7647978      PMCID: PMC1908762          DOI: 10.1111/j.1476-5381.1995.tb16340.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  38 in total

1.  Is pindolol a mixed agonist-antagonist at central serotonin (5-HT) receptors?

Authors:  S Hjorth; A Carlsson
Journal:  Eur J Pharmacol       Date:  1986-09-23       Impact factor: 4.432

2.  Para-chlorophenylalanine prevents feeding induced by the serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT).

Authors:  C T Dourish; P H Hutson; G Curzon
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Hypothermia induced by the putative 5-HT1A agonists LY165163 and 8-OH-DPAT is not prevented by 5-HT depletion.

Authors:  P H Hutson; T P Donohoe; G Curzon
Journal:  Eur J Pharmacol       Date:  1987-11-10       Impact factor: 4.432

4.  Potential antidepressant properties of 8-hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin1A receptor agonist.

Authors:  L Cervo; R Samanin
Journal:  Eur J Pharmacol       Date:  1987-12-01       Impact factor: 4.432

5.  Neuroleptic-induced emotional defecation: effects of scopolamine and haloperidol.

Authors:  P R Sanberg; K H Russell; S H Hagenmeyer-Houser; M Giordano; E M Zubrycki; D L Garver
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  Evidence that central 5-hydroxytryptaminergic neurones are involved in the anxiolytic activity of buspirone.

Authors:  M Carli; C Prontera; R Samanin
Journal:  Br J Pharmacol       Date:  1989-04       Impact factor: 8.739

7.  Activation of the 5-HT1A receptor subtype increases rat plasma ACTH concentration.

Authors:  F Gilbert; C Brazell; M D Tricklebank; S M Stahl
Journal:  Eur J Pharmacol       Date:  1988-03-15       Impact factor: 4.432

8.  Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepam.

Authors:  P C Moser; M D Tricklebank; D N Middlemiss; A K Mir; M F Hibert; J R Fozard
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

9.  Differential localization of 5-HT1 receptors on myenteric and submucosal neurons.

Authors:  J J Galligan; A Surprenant; M Tonini; R A North
Journal:  Am J Physiol       Date:  1988-11

10.  Serotonergic anxiolytics and treatment of depression.

Authors:  D S Robinson; D R Alms; R C Shrotriya; M Messina; P Wickramaratne
Journal:  Psychopathology       Date:  1989       Impact factor: 1.944

View more
  3 in total

Review 1.  Irritable bowel syndrome: new agents targeting serotonin receptor subtypes.

Authors:  F De Ponti; M Tonini
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  Serotonin pharmacology in the gastrointestinal tract: a review.

Authors:  D T Beattie; J A M Smith
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-04-09       Impact factor: 3.000

3.  Pharmacological induction of transforming growth factor-beta1 in rat models enhances radiation injury in the intestine and the heart.

Authors:  Marjan Boerma; Junru Wang; Vijayalakshmi Sridharan; Jean-Marc Herbert; Martin Hauer-Jensen
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.